![Janetta Trochimiuk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Janetta Trochimiuk first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Medical Specialties | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Janetta Trochimiuk via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ONCOLOGY PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ATHENEXPAR | Pharmaceuticals: Major | Corporate Officer/Principal | |
CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Biotechnology | Founder | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Shearwater Corp.
![]() Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Concordia University | College/University | Graduate Degree | |
The University of Waterloo | College/University | Undergraduate Degree | |
Nathan S. Kline Institute for Psychiatric Research
![]() Nathan S. Kline Institute for Psychiatric Research Hospital/Nursing ManagementHealth Services Nathan S. Kline Institute for Psychiatric Research is a non-profit organization, which focuses on studying the causes, treatment, prevention, and rehabilitation of severe and persistent mental illnesses. Its patient-oriented research programs emphasize screening, assessment, diagnosis, treatment, prevention, and care of severe and chronic mental disorders. The company was founded in 1952 and is headquartered in Orangeburg, NY. | Hospital/Nursing Management | Director/Board Member | |
NYU Child Study Center | Founder | ||
The National Board of Medical Examiners, Inc.
![]() The National Board of Medical Examiners, Inc. Medical/Nursing ServicesHealth Services The National Board of Medical Examiners, Inc. provides services to the public through its high- quality assessments of healthcare professionals. It develops customized assessments for the medical specialty boards, other healthcare professions, and academic institutions, while online assessments help students and professionals identify their own strengths and weaknesses. The company was founded in 1915 and is headquartered in Philadelphia, PA. | Medical/Nursing Services | Corporate Officer/Principal | |
Albert Einstein College of Medicine, Inc. | College/University | Graduate Degree | |
Child Mind Institute, Inc.
![]() Child Mind Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Child Mind Institute, Inc. operates an institute that focuses on transforming the lives of children and families who are struggling with mental health and learning disorders. The non-profit company is based in New York, NY. The company was founded by Debra Golding Perelman and Harold S. Koplewicz. | Investment Trusts/Mutual Funds | Founder | |
AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Eboo Pharmaceuticals, Inc. | Director/Board Member | ||
University of Saskatchewan College of Medicine | College/University | Doctorate Degree | |
Ballantyne Therapeutics, Inc.
![]() Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Pharmaceuticals: Major | Director/Board Member | |
Atlantic Research Group, Inc.
![]() Atlantic Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Atlantic Research Group, Inc. operates as a rare disease-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. It offers strategic consulting, clinical trial management services, clinic data and analytics solutions, pharmacovigilance and medical monitoring. The company was founded by Paul Bishop and Lyle Camblos in 2004 and is headquartered in Charlottesville, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Nirogy Therapeutics, Inc.
![]() Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer |
Statistics
International
United States | 21 |
Canada | 5 |
Sectoral
Health Technology | 13 |
Consumer Services | 5 |
Health Services | 3 |
Finance | 2 |
Technology Services | 2 |
Operational
Director/Board Member | 12 |
Corporate Officer/Principal | 7 |
President | 6 |
Independent Dir/Board Member | 5 |
Chief Executive Officer | 5 |
Most connected contacts
Insiders | |
---|---|
Simon Pedder | 19 |
Harold S. Koplewicz | 7 |
- Stock Market
- Insiders
- Janetta Trochimiuk
- Company connections